{"created":"2023-06-23T12:28:38.684934+00:00","id":1218,"links":{},"metadata":{"_buckets":{"deposit":"f342cc8c-1223-443f-9da6-174cb00f04bd"},"_deposit":{"created_by":22,"id":"1218","owners":[22],"pid":{"revision_id":0,"type":"depid","value":"1218"},"status":"published"},"_oai":{"id":"oai:kobe-cufs.repo.nii.ac.jp:00001218","sets":["75"]},"author_link":["445","442","44","463"],"item_10007_biblio_info_24":{"attribute_name":"雑誌名","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2005-03-31","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"18","bibliographicPageEnd":"20","bibliographicPageStart":"1","bibliographic_titles":[{},{"bibliographic_title":"Kobe city university of foreign studies working paper series","bibliographic_titleLang":"en"}]}]},"item_10007_description_13":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"This paper examines how the parallel trade influences the pharmaceutical innovation and welfare. We consider the case where one monopolist in the home potentially sells in the both domestic and foreign markets with different price elasticities of demand. As relevant in the pharmaceutical context, the price of a good sold in the foreign country is determined by the negotiation between the firm and the foreign government. When the parallel trade is allowed, this negotiated foreign price also becomes the domestic price and thus the firm cannot set different price in each market. This paper shows that the parallel trade may enhance pharmaceutical innovation, when the bargaining power of the foreign government is strong and the price elsticity of demand in the foreign market is small.","subitem_description_type":"Abstract"}]},"item_10007_description_19":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_10007_publisher_25":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Institute for foreign studies Kobe city university of foreign studies"}]},"item_10007_relation_18":{"attribute_name":"他の研究成果との関係","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"The revised version of this WP was published : \"Parallel imports, drug price control and pharmaceutical innovation\"『経済学論究(関西学院大学)』第63巻第3号, 2009年 : pp.639-665"}]}]},"item_10007_text_11":{"attribute_name":"著者所属機関","attribute_value_mlt":[{"subitem_text_value":"Kobe City University of Foreign studies"}]},"item_10007_text_26":{"attribute_name":"分類","attribute_value_mlt":[{"subitem_text_value":"JEL classification:F13:I18:L65"}]},"item_10007_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Tabata, Ken"}],"nameIdentifiers":[{"nameIdentifier":"463","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shinkai, Tetsuya"}],"nameIdentifiers":[{"nameIdentifier":"445","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tanaka, Satoru"}],"nameIdentifiers":[{"nameIdentifier":"44","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Okamura, Makoto"}],"nameIdentifiers":[{"nameIdentifier":"442","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2005-03-31"}],"displaytype":"simple","filename":"WPS18.pdf","filesize":[{"value":"2.2 MB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"ダウンロード","url":"https://kobe-cufs.repo.nii.ac.jp/record/1218/files/WPS18.pdf"},"version_id":"e1fa52dd-b7fb-40e4-b032-e95e33f23458"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Parallel Trade","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Pharmaceutical Innovation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Intellectual Property Rights","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"Parallel trade, pharmaceutical innovation, and intellectual property rights","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Parallel trade, pharmaceutical innovation, and intellectual property rights"}]},"item_type_id":"10007","owner":"22","path":["75"],"pubdate":{"attribute_name":"公開日","attribute_value":"2005-03-31"},"publish_date":"2005-03-31","publish_status":"0","recid":"1218","relation_version_is_last":true,"title":["Parallel trade, pharmaceutical innovation, and intellectual property rights"],"weko_creator_id":"22","weko_shared_id":-1},"updated":"2023-06-23T13:11:40.302713+00:00"}